Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Application of a Novel Noninvasive Salivary 1,5-Anhydroglucitol Detection Technology in Diabetes Management

NCT07781683 is registered in ClinicalTrials.gov with Shanghai 6th People's Hospital as lead sponsor.

NCT NCT07781683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07781683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Application of a Novel Noninvasive Salivary 1,5-Anhydroglucitol Detection Technology in Diabetes Management
Lead sponsor
Shanghai 6th People's Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
December 31, 2028
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes (t2dm)